Svas Biosana SpA
MIL:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
Intrinsic Value
The intrinsic value of Svas Biosana SpA (SVS) under the Base Case is 17.68 EUR per share. Compared with the current market price of 8 EUR, the stock appears Undervalued by 55% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Svas Biosana SpA Does
Svas Biosana makes and distributes medical and healthcare products used in hospitals, clinics, and other care settings. Its catalog includes disposable medical devices, surgical supplies, and other items that doctors, nurses, and pharmacists use every day. The company earns money by selling these products to healthcare customers, either under its own brands or as a distributor for third-party manufacturers.
- Headquarters
- Italy IT
- Employees
- 367
- IPO date
- Dec 9, 2021
Earnings Waterfall
Svas Biosana SpA
The intrinsic value for Svas Biosana SpA (SVS) under the Base Case is 17.68 EUR.
Compared with the current market price of 8 EUR, the stock appears Undervalued by 55% .